Study S000532
Effects of Single-dose Semaglutide on Cognition and Energy in Healthy Volunteers
Registration
Registered primary outcomes
- Reward (learning) [6-7 days]
- Reward (effort-based) [6-7 days]
- Reward (primary) [6-7 days]
Linked records (6)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
| Record | Title | Year | Design | Identifiers | Link basis |
|---|---|---|---|---|---|
| R0005203 | Glucagon-Like Peptide-1 Receptor Agonists Collins L, StatPearls Publishing, Treasure Island (FL) | 2024 | Other | PMID 31855395 | registry reference BACKGROUND:31855395 |
| R0007247 | Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression. Detka J, Pharmacological reports : PR | 2021 | Narrative review | PMID 34003475DOI | registry reference BACKGROUND:34003475 |
| R0026671 | A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. Pozzi M, Journal of affective disorders | 2019 | Systematic review | PMID 31153593DOI | registry reference BACKGROUND:31153593 |
| R0022210 | Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials. O'Neil PM, Diabetes, obesity & metabolism | 2017 | Randomized trial | PMID 28386912DOI | registry reference BACKGROUND:28386912 |
| R0022960 | Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study. Mansur RB, Journal of affective disorders | 2017 | Other trial | PMID 27721184DOI | registry reference BACKGROUND:27721184 |
| R0019074 | Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study. Moulton CD, Primary care diabetes | 2016 | Nonrandomized study | PMID 26137918DOI | registry reference BACKGROUND:26137918 |